SCHEMBL5347991

SCHEMBL5347991

Cc1c(Cl)cccc1S(=O)(=O)Nc1ccc2[nH]ncc2c1

nearest known ligand 0.78

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.78
KMT2A Q03164 5/20 0.78
MAPK1 P28482 1/20 0.54
PKM P14618 1/20 0.52
HSD11B1 P28845 2/20 0.51
MAOB P27338 2/20 0.50
ALDH1A1 P00352 2/20 0.49
MAPT P10636 1/20 0.49
POLB P06746 1/20 0.49
CASP6 P55212 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ROCK2 O75116 1/20 0.49
ROCK1 Q13464 1/20 0.49
NPC1 O15118 1/20 0.49
JAK2 O60674 1/20 0.49
JAK1 P23458 1/20 0.49
RAB9A P51151 1/20 0.49
SLC40A1 Q9NP59 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5491142 0.88 MEN1 (1.00) MEN1KMT2AMAPK1PKMMAOB
SCHEMBL616758 0.81 HSD11B1 (0.53) MEN1KMT2APKMHSD11B1MAOB
SCHEMBL615849 0.81 IDH1 (0.52) MEN1KMT2APKMHSD11B1SLC40A1
SCHEMBL1460530 0.81 MEN1 (0.73) MEN1KMT2AMAPK1PKMALDH1A1
SCHEMBL616421 0.79 HSD11B1 (0.51) MEN1KMT2APKMHSD11B1ALDH1A1
SCHEMBL5339534 0.77 EDNRA (0.52) MEN1KMT2AHSD11B1ALDH1A1SLC40A1
SCHEMBL31702293 0.77 PKM (0.64) MEN1KMT2APKMALDH1A1MAPT
SCHEMBL618067 0.76 BRD4 (0.56) MEN1KMT2APKMHSD11B1MAPT
SCHEMBL5343689 0.76 HSD11B1 (0.60) MEN1KMT2APKMHSD11B1ALDH1A1
SCHEMBL617497 0.76 ESR1 (0.58) MEN1KMT2APKMHSD11B1SLC40A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
EP-1675844-A1 PHENYL CARBOXAMIDE AND SULFONAMIDE DERIVATIVES FOR USE AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE Sterix Limited (GB) 2006-07-05 EP disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed
WO-2005042513-A1 PHENYL CARBOXAMIDE AND SULFONAMIDE DERIVATIVES FOR USE AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE STERIX LIMITED (GB) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 MEN1 2978/4885KMT2A 1973/4885MAPK1 3471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.